Jose Moya Sánchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jose Moya Sánchez has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Domínguez-Gil
Organización Nacional de Trasplantes, Madrid, Spain
4 shared publications - Mario Royo-Villanova
Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
4 shared publications - Alejandro Ortín
Donor Transplant Coordination Unit. Service of Intensive Care. Hospital Universitario Virgen de la Arrixaca. Murcia, Spain. Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, 30120 Murcia, Spain
2 shared publications - Alicia Pérez-Blanco
Organización Nacional de Trasplantes, Madrid, Spain
2 shared publications A. Andreu Ruiz
Servicio de Medicina Intensiva, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, España
1 shared publication- Borja Suberviola
Intensive Care Department, University Hospital Marques de Valdecilla, Valdecilla Research Institute (IDIVAL), 39008 Santander, Spain
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 449
Letter to the Editor: “Organ donation after ECPR: ethical challenges and clinical implications”
- 27 August 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 449
Open AccessLetter to the Editor: “Organ donation after ECPR: ethical challenges and clinical implications”
- 26 February 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1745-1754
Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death
- 26 February 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1745-1754
Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death
- Open Access
- 14 September 2025
- Published by MDPI AG in Medical Sciences
- Vol. 13 (3) , 188
Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis
Background: The shortage of donor kidneys has prompted interest in using organs from donors with severe acute kidney injury (AKI), but robust data on outcomes from donors with AKIN stage 3 remain limited. Methods: This single-centre, retrospective cohort study compared outcomes of kidney transplants from deceased donors with AKIN stage 3 AKI to matched non-AKI donors (n = 57 per group; matched by donor age ±5 years, year of transplant, and major cardiovascular risk factors). Primary outcomes were delayed graft function (DGF), death-censored graft survival, and patient survival. Secondary outcomes included renal function at follow-up. Results: DGF occurred in 54.4% (31/57) of AKIN 3 recipients vs. 33.3% (19/57) of non-AKI recipients (risk difference 21.1%, 95% CI 3.1–39.2; p = 0.037). Five-year death-censored graft survival was 94.7% vs. 96.4% (HR 1.28, 95% CI 0.25–6.52; p = 0.645). Five-year patient survival was 84.8% vs. 84.0% (HR 0.96, 95% CI 0.30–3.05; p = 0.979). Median follow-up was 32 months. Conclusions: In this preliminary, selected kidneys from AKIN stage 3 donors yielded similar medium-term graft and patient survival to non-AKI donors, despite higher DGF incidence. Findings should be interpreted cautiously and confirmed in adequately powered, multicentre studies with extended follow-up.
- 14 September 2025
- Published by MDPI AG in Medical Sciences
- Vol. 13 (3) , 188
Open AccessOutcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis
Background: The shortage of donor kidneys has prompted interest in using organs from donors with severe acute kidney injury (AKI), but robust data on outcomes from donors with AKIN stage 3 remain limited. Methods: This single-centre, retrospective cohort study compared outcomes of kidney transplants from deceased donors with AKIN stage 3 AKI to matched non-AKI donors (n = 57 per group; matched by donor age ±5 years, year of transplant, and major cardiovascular risk factors). Primary outcomes were delayed graft function (DGF), death-censored graft survival, and patient survival. Secondary outcomes included renal function at follow-up. Results: DGF occurred in 54.4% (31/57) of AKIN 3 recipients vs. 33.3% (19/57) of non-AKI recipients (risk difference 21.1%, 95% CI 3.1–39.2; p = 0.037). Five-year death-censored graft survival was 94.7% vs. 96.4% (HR 1.28, 95% CI 0.25–6.52; p = 0.645). Five-year patient survival was 84.8% vs. 84.0% (HR 0.96, 95% CI 0.30–3.05; p = 0.979). Median follow-up was 32 months. Conclusions: In this preliminary, selected kidneys from AKIN stage 3 donors yielded similar medium-term graft and patient survival to non-AKI donors, despite higher DGF incidence. Findings should be interpreted cautiously and confirmed in adequately powered, multicentre studies with extended follow-up.
- Top Cited PapersOpen Access
- 31 March 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1670-1676
A scintigraphic look at the dead donor rule in donation after the circulatory determination of death with the use of normothermic regional perfusion: A single-center interventional trial
- 31 March 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1670-1676
Top Cited PapersOpen AccessA scintigraphic look at the dead donor rule in donation after the circulatory determination of death with the use of normothermic regional perfusion: A single-center interventional trial
- 1 January 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (1) , 1-8
Minigammacámara portátil para el diagnóstico de muerte encefálica
- 1 January 2020
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 44 (1) , 1-8
Minigammacámara portátil para el diagnóstico de muerte encefálica